T cells from patients with melanoma can trigger a protective immune response against the disease according to data from an in vitro and animal study. The findings were published in the Journal of Immunotherapy (2015; doi:10.1097/CJI.0000000000000078).
MRV Research
NF1 Gene’s Key Role in Melanoma Highlighted and Clarified
Researchers at Yale report that they have defined a subgroup of genetic mutations that are present in a significant number of melanoma skin cancer cases. Their findings highlighted an important mutation in this deadly disease, and may lead to more targeted anti-cancer therapies.
Researchers find five new melanoma ‘risk regions’
Australian researchers have identified five new genetic variants which increase a person’s risk of developing melanoma.
The study, which used blood samples from more than 12,000 patients with melanoma, raises the potential for developing new treatments for the cancer which kills about 1500 Australians a year.
Yale study identifies ‘major player’ in skin cancer genes
A multidisciplinary team at Yale, led by Yale Cancer Center members, has defined a subgroup of genetic mutations that are present in a significant number of melanoma skin cancer cases. Their findings shed light on an important mutation in this deadly disease, and may lead to more targeted anti-cancer therapies.